Evidence map›Paper›PMID 35664249›Full record

ArticleObesity science & practice2022

Effect of ideal protein versus low-fat diet for weight loss: A randomized controlled trial.

Camilo A Fernandez, Kaitlin Potts, Lydia A Bazzano

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Obesity science & practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03515889 (A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03515889 nacompletednot on this map

A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss

TypeinterventionalSponsorTulane UniversityRan2018 to 2020Enrolled192ConditionsWeight LossArmsIdeal Protein Weight Loss Method, Standard Weight Loss
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Camilo A FernandezDepartment of Epidemiology Tulane University School of Public Health and Tropical Medicine New Orleans Louisiana USA.
Kaitlin PottsDepartment of Epidemiology Tulane University School of Public Health and Tropical Medicine New Orleans Louisiana USA.
Lydia A BazzanoDepartment of Epidemiology Tulane University School of Public Health and Tropical Medicine New Orleans Louisiana USA.ORCID https://orcid.org/0000-0002-8958-1352
Tulane University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Current guidelines call for peer-reviewed evidence of efficacy and safety for commercial weight loss programs to be recommended as options for those seeking to lose weight. Objectives: This study investigated the Ideal Protein (IP) system, a commercial weight loss program, compared to a guideline-based, low-calorie/low-fat (LCLF) dietary behavioral intervention on body weight and CVD risk factors in adults with obesity. Methods: In this randomized, assessor-blinded, parallel-group trial, 192 participants with body mass index (BMI) ≥30 and ≤49 kg/m Results: The mean ± SD of change in weight at 3 months was -9.6 ± 12.7 kg in the IP group as compared to -1.6 ± 27.2 kg in the LFLC group. The mean between-group difference in change at 3 months was -8.1 kg (95% confidence interval [CI] -16.6 to 0.6; Conclusions: The present findings demonstrate the efficacy and safety of the IP weight loss program as compared to a guideline-based LCLF dietary behavioral intervention among black and white adults with obesity and CVD risk factors, providing support for the effectiveness of the program.

Indexed as

carbohydrate‐restricteddietenergy intakefoodnutritionweight loss

Identifiers

PMID35664249
PMCPMC9159558
OpenAlexW3204646219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.